Thomas Jahn, based in California, United States, is currently a Chief Medical Officer at Trishula Therapeutics, Inc., bringing experience from previous roles at Apexigen, RAPT Therapeutics, Kartos Therapeutics and AbbVie. Thomas Jahn holds a 2006 - 2009 Instructor in Pediatrics @ Stanford University School of Medicine. With a robust skill set that includes Clinical Research Experience, Molecular Medicine, Hematology, Leukemia, Cell Signaling and more, Thomas Jahn contributes valuable insights to the industry. Thomas Jahn has 6 emails on RocketReach.